Liver transplants succeed in many hepatitis C patients

People with the liver-wrecking hepatitis C virus who receive liver transplants are usually considered to have poor prospects because physicians expect the disease to attack the transplant within a few years. But researchers now report that these hepatitis C patients fare about as well over the decade following the procedure as do patients receiving liver transplants to ameliorate other conditions.

More than one-third of the livers transplanted in the United States go to hepatitis C patients.

Researchers tracked the progress of liver transplants in 135 people with hepatitis C and 608 people with other liver diseases. After 10 years, 67 percent of the hepatitis C patients were still alive, compared with 59 percent of the others, scientists report in the September Liver Transplantation. People with liver cancer or hepatitis B fared the worst.

Previous studies had suggested that liver transplants in hepatitis C patients were more likely to fail because the virus remains in the body even after a person’s liver is replaced, says study coauthor Russell H. Wiesner, a hepatologist at the Mayo Clinic in Rochester, Minn. Indeed, the main cause of liver problems following a transplant in hepatitis C patients is the virus.

The new study shows that any life-threatening problem occurring in patients with hepatitis C generally came several years after transplant surgery. In the first 90 days after the operation, hepatitis C virus wasn’t responsible for any of the severe health problems that occurred. They were usually caused by other infections or the failure of the transplanted organ to thrive.

More Stories from Science News on Health & Medicine